Ben Derman, Assistant Professor at University of Chicago, shared on X about a recent paper by Abigail P. Sneider et al. published on Leukemia & Lymphoma:
“What’s the data supporting maintenance therapy in myeloma (esp. in current era)?
What happens after patients stop treatment?
Should we recommend maintenance cessation for patients with sustained MRD negativity in myeloma?
Proud of trainee Abigail Sneider for helping to put together this comprehensive review!”
Title: The role of maintenance therapy and its cessation in patients with multiple myeloma
Authors: Abigail P. Sneider and Ben Derman
More posts featuring Multiple Myeloma.
